STERIS Announces Election of Jacqueline Kosecoff, PhD to Board of Directors
MENTOR, Ohio -- STERIS Corporation announces that Jacqueline Kosecoff, PhD has been elected to the company's board of directors. With the addition of Kosecoff, the STERIS board now consists of nine members.
Kosecoff serves as executive vice president of pharmaceutical services for PacifiCare, one of the nation's largest consumer health organizations. Prior to joining PacifiCare, Kosecoff founded Protocare, Inc., a firm involved in the development and testing of drugs, devices, biopharmaceutical and nutritional products, where she served for four years as the company's president. She is also the founder and former co-CEO and president of Value Health Sciences, a wholly owned subsidiary of Value Health, Inc., and co-founder of Chassin & Kosecoff Medical Systems.
Commenting on the election, Les C. Vinney, STERIS's president and CEO, said, "We are pleased to have Dr. Kosecoff join the STERIS board of directors. Jaqueline brings a wealth of business development and operations management experience gained in the healthcare and pharmaceutical industries. Her experience and unique background make her an excellent person to help STERIS achieve its long-term growth objectives. We look forward to working with Jaqueline and drawing upon her expertise and counsel."
Kosecoff earned a bachelor's degree from the University of California, Los Angeles (UCLA), a master's degree in applied mathematics from Brown University, and a PhD in research methods from UCLA. In addition to her entrepreneurial accomplishments, Kosecoff is an expert in quality of care assessment, has been published in several medical journals, and has served as professor of medicine and public health at UCLA, where she still holds a research professorship.
The mission of STERIS Corporation is to provide a healthier today and safer tomorrow through knowledgeable people and innovative infection prevention, decontamination and health science technologies, products and services.
Source: STERIS Corporation
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.
